This inventor holds 25 USPTO granted patents and 4 published patent applications and 1 EPO patent, primarily in Cardiac Neuromodulation. Top assignees: East Tennessee State University, Cyberonics, Inc., Livanova USA, Inc.. Active years: 2010-2024.
Company Filing History:
20 out of 28Â 
12 out of 257Â 
9 out of 84Â 
Years Active: 2010-2024
Areas of Expertise:
Title: Innovations in Neurostimulation: The Contributions of Jeffrey L. Ardell
Introduction
Jeffrey L. Ardell, based in Johnson City, Tennessee, has made significant advancements in the field of neurostimulation, accumulating an impressive total of 25 patents throughout his career. His innovative work primarily focuses on the treatment of chronic cardiac dysfunction, showcasing his dedication to improving patient outcomes through novel technologies.
Latest Patents
Among his latest inventions, Ardell has developed groundbreaking patents related to responsive neurostimulation for the treatment of chronic cardiac dysfunction. These systems and methods provide targeted neurostimulation therapies aimed at treating chronic heart failure. The approach involves identifying a neural fulcrum zone to deliver ongoing therapy effectively. The implanted stimulation device is equipped with a physiological sensor that continuously monitors the patient's response to the treatment over extended periods. Additionally, a control system adjusts stimulation parameters based on any detected changes in physiological responses, thereby maintaining optimal stimulation within the designated neural fulcrum zone. Another key patent centers on neurostimulation in this same region, achieving autonomic engagement while minimizing side effects, such as significant fluctuations in heart rate.
Career Highlights
Throughout his career, Jeffrey L. Ardell has worked with reputable institutions, most notably East Tennessee State University and Cyberonics, Inc. His positions at these organizations have allowed him to contribute significantly to research and development within the neurostimulation domain, fostering innovations that have practical applications in treating heart failure.
Collaborations
Collaboration has been an important aspect of Ardell's work. He has partnered with esteemed colleagues such as Badri Amurthur and Bruce H. KenKnight, further enhancing the research and development efforts in neurostimulation technologies. These collaborations have led to the successful outcomes of various projects and patents.
Conclusion
Jeffrey L. Ardell stands out as a prominent inventor in the field of neurostimulation, with a clear focus on therapeutic applications for chronic cardiac dysfunction. His 25 patents reflect a commitment to innovation and improvement in healthcare technology, positioning him as a significant contributor to medical advancements in his field.